An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models-Reference-Cited by-同舟云学术

An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models

Published:2016-11 Issue: Volume:110 Page:48-58
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Ko Wai Kin D.,Camus Sandrine M.^ORCID,Li Qin,Yang Jianzhong,McGuire Steve,Pioli Elsa Y.,Bezard Erwan^ORCID

Funder

Motac Neuroscience Ltd

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference91 articles.

1. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov. Disord.,2001

2. Functional architecture of basal ganglia circuits: neural substrates of parallel processing;Alexander;Trends Neurosci.,1990

3. Parallel organization of functionally segregated circuits linking basal ganglia and cortex;Alexander;Annu. Rev. Neurosci.,1986

4. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia;Aubert;Ann. Neurol.,2005

5. Adenosine A(2A) receptor antagonist treatment of Parkinson's disease;Bara-Jimenez;Neurology,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson’s disease through anti-oxidant capacities;PLOS ONE;2024-04-16

2. Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease;Neuropharmacology;2024-04

3. Behavioral effects of 6-hydroxydopamine-induced damage to nigro-striatal pathway and Locus coeruleus as a rodent model of Parkinson’s disease;Behavioural Brain Research;2024-03

4. Nutraceuticals in the management of Parkinson’s disease and dementia;Nutraceutical Fruits and Foods for Neurodegenerative Disorders;2024

5. Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches;Medicina;2023-10-01